Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Alamar Biosciences Inc

ALMR ✓ COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Advanced Medical Equipment & Technology ·

USA Mid Cap Analyst: BUY

Last Close

$34.24

▼ -1.15%

Market Cap $2.38B · Vol 77.23K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$2.38B

Mid Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

67.43

Momentum

Beta

N/A

vs Market

52W High

$38.28

10.54% below

52W Low

$18.85

81.64% above

Volume

77.23K

Avg 87.40K

P/B

N/A

Price-to-book

ROE

N/A

Return on equity

Free Float

73.36%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Alamar Biosciences Inc (ALMR) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does ALMR pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+3.26%

+36.14%

+55.64%

N/A

YTD

N/A

Financials & Valuation

TTM · Annual

Total Revenue	$74.21M
Net Income	$-29,819,000.00
Revenue Growth (YoY)	+82.08%
Gross Margin	56.20%
Operating Margin	-42.22%
Net Profit Margin	-40.18%
ROE	N/A
ROA · ROIC	-20.14% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	N/A
P/B	N/A
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	69.39M

Technical Indicators

50-Day SMA	$26.84
200-Day SMA	$N/A
RSI (14)	67.43
Beta	N/A
52-Week High	$38.28
52-Week Low	$18.85

Volume Today	77.23K
Avg Daily Volume (30D)	87.40K
Relative Volume	0.88x
Volatility (10D)	146.95
Volatility (30D)	98.46
Free Float	73.36%

Analyst Consensus

BUY

Current Price $34.24

Mean Target $33.00

52W Low$18.85 52W High$38.28

Current

Target

$18.85 $38.28

Current Analyst target

-3.62% downside risk · 5 analysts

Identifiers

ExchangeNasdaq

FIGIBBG012FD22X6

ISINUS0109111056

CountryUnited States of America

Sub-IndustryAdvanced Medical Equipment & Technology (NEC)

Earnings DateNov 10, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

TMO Thermo Fisher Scientific Inc +0.27% DHR Danaher Corp +1.36% ISRG Intuitive Surgical Inc +1.16% BSX Boston Scientific Corp +2.03% SHL.DE Siemens Healthineers AG +0.98%

Company Profile

Alamar Biosciences, Inc. is a commercial-stage proteomics company engaged in protein detection and analysis. The Company's proprietary NULISA (Nucleic Acid Linked Immuno-Sandwich Assay) technology addresses the limitations of existing proteomics tools by detecting protein biomarkers at extremely low concentrations in non-invasive biological fluids, such as blood, with ultra-high sensitivity, high specificity, flexible multiplexing, dynamic range and automation. Its integrated platform consists of proprietary instruments, consumables and analytical software that is designed to provide scientists with an end-to-end solution to precisely and consistently measure from one to hundreds of low-abundances and difficult-to-detect biomarkers across the continuum of discovery, translational research and ultimately diagnostics. Its instrument, the ARGO HT System, is designed to automate high-sensitivity and high-plex proteomics analysis and is available for research use only applications.